CEO talks about KY company that developed Ebola treatment

Published: Mar. 11, 2015 at 9:53 PM CDT|Updated: May. 19, 2016 at 9:27 PM CDT
Email This Link
Share on Pinterest
Share on LinkedIn

OWENSBORO, KY (WFIE) - Kentucky Bioprocessing CEO Hugh Hayden was the guest speaker at the Green River Area Development District's Board of Directors Meeting on Wednesday.

Hayden spoke on the history of Kentucky Bioprocessing and their work developing a treatment for Ebola.

Kentucky Bioprocessing uses tobacco leaves to make the drug "ZMapp" for the disease.

In his presentation, Hayden praised the people who work at Kentucky Bioprocessing.

"We're proud to be part of the region, proud of the people that we have who've done an incredible job, most of those people are born, raised, educated right here in this part of the country and are doing great and amazing things," said Hayden.

Hayden says Kentucky Bioprocessing was given FDA approval to do clinical studies of their product on ill people in Africa in February.

Copyright 2015 WFIE. All rights reserved.